Early strategy of scepter XC balloon angioplasty and simultaneous Nimodipine infusion for vasospasm following ruptured aneurysm
Background Cerebral vasospasm still results in high morbidity and mortality rates in patients after aneurysmal subarachnoid hemorrhage (SAH). The aim of this study was to establish a protocol for the management of vasospasm and demonstrate our experience of angioplasty using the Scepter XC balloon c...
Saved in:
Published in | BMC neurology Vol. 20; no. 1; pp. 1 - 8 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
07.07.2020
BioMed Central Ltd BMC |
Subjects | |
Online Access | Get full text |
ISSN | 1471-2377 1471-2377 |
DOI | 10.1186/s12883-020-01856-4 |
Cover
Abstract | Background
Cerebral vasospasm still results in high morbidity and mortality rates in patients after aneurysmal subarachnoid hemorrhage (SAH). The aim of this study was to establish a protocol for the management of vasospasm and demonstrate our experience of angioplasty using the Scepter XC balloon catheter.
Methods
In this retrospective study, a computed tomography angiography and perfusion image was arranged if early symptoms occurred or on the 7th day following aneurysmal SAH. In patients with clear consciousness, balloon angioplasties were performed for symptomatic vasospasms, which were not improved within 6–12 h after maximal medical treatments. In unconscious patients, balloon angioplasties were performed for all patients with angiographic vasospasms.
Results
Fifty patients underwent Scepter XC balloon angioplasty among 396 consecutive patients who accepted endovascular or surgical treatments for ruptured aneurysms. All angioplasty procedures were successful without complications. 100% angiographic improvement and 94% clinical improvement were reached immediately after the angioplasties. A favorable functional outcome (modified Rankin Score of ≤2) could be achieved in 82% of patients. Even in patients with poor clinical grading (Hunt–Hess grade 4–5), a clinical improvement rate of 87.5% and favorable outcome rate was 70.8% could be achieved.
Conclusion
Balloon angioplasty with Scepter XC balloon catheter is safe and effective for post-SAH vasospasm. This device’s extra-compliant characteristics could considerably improve the quality of angioplasty procedures. For all patients, even those with poor neurological status, early treatment with combined protocol of nimodipine and angioplasty can have good clinical outcomes. |
---|---|
AbstractList | Cerebral vasospasm still results in high morbidity and mortality rates in patients after aneurysmal subarachnoid hemorrhage (SAH). The aim of this study was to establish a protocol for the management of vasospasm and demonstrate our experience of angioplasty using the Scepter XC balloon catheter. In this retrospective study, a computed tomography angiography and perfusion image was arranged if early symptoms occurred or on the 7th day following aneurysmal SAH. In patients with clear consciousness, balloon angioplasties were performed for symptomatic vasospasms, which were not improved within 6-12 h after maximal medical treatments. In unconscious patients, balloon angioplasties were performed for all patients with angiographic vasospasms. Fifty patients underwent Scepter XC balloon angioplasty among 396 consecutive patients who accepted endovascular or surgical treatments for ruptured aneurysms. All angioplasty procedures were successful without complications. 100% angiographic improvement and 94% clinical improvement were reached immediately after the angioplasties. A favorable functional outcome (modified Rankin Score of [less than or equai to]2) could be achieved in 82% of patients. Even in patients with poor clinical grading (Hunt-Hess grade 4-5), a clinical improvement rate of 87.5% and favorable outcome rate was 70.8% could be achieved. Balloon angioplasty with Scepter XC balloon catheter is safe and effective for post-SAH vasospasm. This device's extra-compliant characteristics could considerably improve the quality of angioplasty procedures. For all patients, even those with poor neurological status, early treatment with combined protocol of nimodipine and angioplasty can have good clinical outcomes. Background Cerebral vasospasm still results in high morbidity and mortality rates in patients after aneurysmal subarachnoid hemorrhage (SAH). The aim of this study was to establish a protocol for the management of vasospasm and demonstrate our experience of angioplasty using the Scepter XC balloon catheter. Methods In this retrospective study, a computed tomography angiography and perfusion image was arranged if early symptoms occurred or on the 7th day following aneurysmal SAH. In patients with clear consciousness, balloon angioplasties were performed for symptomatic vasospasms, which were not improved within 6–12 h after maximal medical treatments. In unconscious patients, balloon angioplasties were performed for all patients with angiographic vasospasms. Results Fifty patients underwent Scepter XC balloon angioplasty among 396 consecutive patients who accepted endovascular or surgical treatments for ruptured aneurysms. All angioplasty procedures were successful without complications. 100% angiographic improvement and 94% clinical improvement were reached immediately after the angioplasties. A favorable functional outcome (modified Rankin Score of ≤2) could be achieved in 82% of patients. Even in patients with poor clinical grading (Hunt–Hess grade 4–5), a clinical improvement rate of 87.5% and favorable outcome rate was 70.8% could be achieved. Conclusion Balloon angioplasty with Scepter XC balloon catheter is safe and effective for post-SAH vasospasm. This device’s extra-compliant characteristics could considerably improve the quality of angioplasty procedures. For all patients, even those with poor neurological status, early treatment with combined protocol of nimodipine and angioplasty can have good clinical outcomes. Background Cerebral vasospasm still results in high morbidity and mortality rates in patients after aneurysmal subarachnoid hemorrhage (SAH). The aim of this study was to establish a protocol for the management of vasospasm and demonstrate our experience of angioplasty using the Scepter XC balloon catheter. Methods In this retrospective study, a computed tomography angiography and perfusion image was arranged if early symptoms occurred or on the 7th day following aneurysmal SAH. In patients with clear consciousness, balloon angioplasties were performed for symptomatic vasospasms, which were not improved within 6–12 h after maximal medical treatments. In unconscious patients, balloon angioplasties were performed for all patients with angiographic vasospasms. Results Fifty patients underwent Scepter XC balloon angioplasty among 396 consecutive patients who accepted endovascular or surgical treatments for ruptured aneurysms. All angioplasty procedures were successful without complications. 100% angiographic improvement and 94% clinical improvement were reached immediately after the angioplasties. A favorable functional outcome (modified Rankin Score of ≤2) could be achieved in 82% of patients. Even in patients with poor clinical grading (Hunt–Hess grade 4–5), a clinical improvement rate of 87.5% and favorable outcome rate was 70.8% could be achieved. Conclusion Balloon angioplasty with Scepter XC balloon catheter is safe and effective for post-SAH vasospasm. This device’s extra-compliant characteristics could considerably improve the quality of angioplasty procedures. For all patients, even those with poor neurological status, early treatment with combined protocol of nimodipine and angioplasty can have good clinical outcomes. Cerebral vasospasm still results in high morbidity and mortality rates in patients after aneurysmal subarachnoid hemorrhage (SAH). The aim of this study was to establish a protocol for the management of vasospasm and demonstrate our experience of angioplasty using the Scepter XC balloon catheter.BACKGROUNDCerebral vasospasm still results in high morbidity and mortality rates in patients after aneurysmal subarachnoid hemorrhage (SAH). The aim of this study was to establish a protocol for the management of vasospasm and demonstrate our experience of angioplasty using the Scepter XC balloon catheter.In this retrospective study, a computed tomography angiography and perfusion image was arranged if early symptoms occurred or on the 7th day following aneurysmal SAH. In patients with clear consciousness, balloon angioplasties were performed for symptomatic vasospasms, which were not improved within 6-12 h after maximal medical treatments. In unconscious patients, balloon angioplasties were performed for all patients with angiographic vasospasms.METHODSIn this retrospective study, a computed tomography angiography and perfusion image was arranged if early symptoms occurred or on the 7th day following aneurysmal SAH. In patients with clear consciousness, balloon angioplasties were performed for symptomatic vasospasms, which were not improved within 6-12 h after maximal medical treatments. In unconscious patients, balloon angioplasties were performed for all patients with angiographic vasospasms.Fifty patients underwent Scepter XC balloon angioplasty among 396 consecutive patients who accepted endovascular or surgical treatments for ruptured aneurysms. All angioplasty procedures were successful without complications. 100% angiographic improvement and 94% clinical improvement were reached immediately after the angioplasties. A favorable functional outcome (modified Rankin Score of ≤2) could be achieved in 82% of patients. Even in patients with poor clinical grading (Hunt-Hess grade 4-5), a clinical improvement rate of 87.5% and favorable outcome rate was 70.8% could be achieved.RESULTSFifty patients underwent Scepter XC balloon angioplasty among 396 consecutive patients who accepted endovascular or surgical treatments for ruptured aneurysms. All angioplasty procedures were successful without complications. 100% angiographic improvement and 94% clinical improvement were reached immediately after the angioplasties. A favorable functional outcome (modified Rankin Score of ≤2) could be achieved in 82% of patients. Even in patients with poor clinical grading (Hunt-Hess grade 4-5), a clinical improvement rate of 87.5% and favorable outcome rate was 70.8% could be achieved.Balloon angioplasty with Scepter XC balloon catheter is safe and effective for post-SAH vasospasm. This device's extra-compliant characteristics could considerably improve the quality of angioplasty procedures. For all patients, even those with poor neurological status, early treatment with combined protocol of nimodipine and angioplasty can have good clinical outcomes.CONCLUSIONBalloon angioplasty with Scepter XC balloon catheter is safe and effective for post-SAH vasospasm. This device's extra-compliant characteristics could considerably improve the quality of angioplasty procedures. For all patients, even those with poor neurological status, early treatment with combined protocol of nimodipine and angioplasty can have good clinical outcomes. Background Cerebral vasospasm still results in high morbidity and mortality rates in patients after aneurysmal subarachnoid hemorrhage (SAH). The aim of this study was to establish a protocol for the management of vasospasm and demonstrate our experience of angioplasty using the Scepter XC balloon catheter. Methods In this retrospective study, a computed tomography angiography and perfusion image was arranged if early symptoms occurred or on the 7th day following aneurysmal SAH. In patients with clear consciousness, balloon angioplasties were performed for symptomatic vasospasms, which were not improved within 6-12 h after maximal medical treatments. In unconscious patients, balloon angioplasties were performed for all patients with angiographic vasospasms. Results Fifty patients underwent Scepter XC balloon angioplasty among 396 consecutive patients who accepted endovascular or surgical treatments for ruptured aneurysms. All angioplasty procedures were successful without complications. 100% angiographic improvement and 94% clinical improvement were reached immediately after the angioplasties. A favorable functional outcome (modified Rankin Score of [less than or equai to]2) could be achieved in 82% of patients. Even in patients with poor clinical grading (Hunt-Hess grade 4-5), a clinical improvement rate of 87.5% and favorable outcome rate was 70.8% could be achieved. Conclusion Balloon angioplasty with Scepter XC balloon catheter is safe and effective for post-SAH vasospasm. This device's extra-compliant characteristics could considerably improve the quality of angioplasty procedures. For all patients, even those with poor neurological status, early treatment with combined protocol of nimodipine and angioplasty can have good clinical outcomes. Keywords: Balloon angioplasty; subarachnoid hemorrhage, Cerebral aneurysm, Aneurysm rupture, Scepter XC balloon Abstract Background Cerebral vasospasm still results in high morbidity and mortality rates in patients after aneurysmal subarachnoid hemorrhage (SAH). The aim of this study was to establish a protocol for the management of vasospasm and demonstrate our experience of angioplasty using the Scepter XC balloon catheter. Methods In this retrospective study, a computed tomography angiography and perfusion image was arranged if early symptoms occurred or on the 7th day following aneurysmal SAH. In patients with clear consciousness, balloon angioplasties were performed for symptomatic vasospasms, which were not improved within 6–12 h after maximal medical treatments. In unconscious patients, balloon angioplasties were performed for all patients with angiographic vasospasms. Results Fifty patients underwent Scepter XC balloon angioplasty among 396 consecutive patients who accepted endovascular or surgical treatments for ruptured aneurysms. All angioplasty procedures were successful without complications. 100% angiographic improvement and 94% clinical improvement were reached immediately after the angioplasties. A favorable functional outcome (modified Rankin Score of ≤2) could be achieved in 82% of patients. Even in patients with poor clinical grading (Hunt–Hess grade 4–5), a clinical improvement rate of 87.5% and favorable outcome rate was 70.8% could be achieved. Conclusion Balloon angioplasty with Scepter XC balloon catheter is safe and effective for post-SAH vasospasm. This device’s extra-compliant characteristics could considerably improve the quality of angioplasty procedures. For all patients, even those with poor neurological status, early treatment with combined protocol of nimodipine and angioplasty can have good clinical outcomes. |
ArticleNumber | 271 |
Audience | Academic |
Author | Chen, Chun-Ting Wu, Yi-Ming Hsieh, Po-Chuan Hsu, Shih-Yuan Wang, Alvin Yi-Chou Chen, Ching-Chang Lin, Ya-Jui Yeap, Mun-Chun Chin, Shy-Chyi |
Author_xml | – sequence: 1 givenname: Chun-Ting surname: Chen fullname: Chen, Chun-Ting organization: Department of Neurosurgery, Stroke Center & Neurointervention, Chang Gung Memorial Hospital, Chang Gung Medical Center and University – sequence: 2 givenname: Ching-Chang orcidid: 0000-0001-6816-3963 surname: Chen fullname: Chen, Ching-Chang email: jcchen130@gmail.com, 8702047@cgmh.org.tw organization: Department of Neurosurgery, Stroke Center & Neurointervention, Chang Gung Memorial Hospital, Chang Gung Medical Center and University – sequence: 3 givenname: Alvin Yi-Chou surname: Wang fullname: Wang, Alvin Yi-Chou organization: Department of Neurosurgery, Guangdong Provincial Hospital of Chinese Medicine – sequence: 4 givenname: Yi-Ming surname: Wu fullname: Wu, Yi-Ming organization: Department of Radiology, Division of Neuroradiology, Linkou Chang Gung Memorial Hospital & Chang Gung University – sequence: 5 givenname: Shy-Chyi surname: Chin fullname: Chin, Shy-Chyi organization: Department of Radiology, Division of Neuroradiology, Linkou Chang Gung Memorial Hospital & Chang Gung University – sequence: 6 givenname: Po-Chuan surname: Hsieh fullname: Hsieh, Po-Chuan organization: Department of Neurosurgery, Stroke Center & Neurointervention, Chang Gung Memorial Hospital, Chang Gung Medical Center and University – sequence: 7 givenname: Mun-Chun surname: Yeap fullname: Yeap, Mun-Chun organization: Department of Neurosurgery, Stroke Center & Neurointervention, Chang Gung Memorial Hospital, Chang Gung Medical Center and University – sequence: 8 givenname: Shih-Yuan surname: Hsu fullname: Hsu, Shih-Yuan organization: Department of Neurosurgery, Kaohsiung Chang Gung Memorial Hospital – sequence: 9 givenname: Ya-Jui surname: Lin fullname: Lin, Ya-Jui organization: Department of Neurosurgery, Stroke Center & Neurointervention, Chang Gung Memorial Hospital, Chang Gung Medical Center and University |
BookMark | eNp9kktv1DAUhSNURB_wB1hFYsMmrd92NkjVqEClCjYgsbMcxwkeJXawk6JZ8de501QtU6EqCz9yznd1r89pcRRicEXxFqNzjJW4yJgoRStEUIWw4qJiL4oTzCSuCJXy6J_9cXGa8xYhLBXDr4pjSgTlqiYnxZ8rk4ZdmedkZtfvytiV2bppdqn8sSkbMwwxhtKE3sdpMHnewb4tsx-XYTbBxSWXX_wYWz_54EofuiV7MHQxlbcmxzyZPMIJML996Mu0TPOSXAsUt6RdHl8XLzszZPfmfj0rvn-8-rb5XN18_XS9ubypLFdsrljHnGw6SbisLa0Fb3AniBTGtjUSkjGCOowlUkwoyQRyiDusCBwMrmld07PieuW20Wz1lPxo0k5H4_XdRUy9Nmn2dnC6bYzgjrGWN4hJi2tBDMBMVxuOGLXA-rCypqUZXWtdgOkNB9DDP8H_1H281ZLSmlMMgPf3gBR_LS7PevQw9WFYJ6oJI5gJLjgF6bsn0m1cUoBR7VVMwrMr8ajqDTQArxChrt1D9aWAkNQQgj3r_D8q-Fo3egvZ6jzcHxjIarAp5pxc99AjRnofQb1GUEME9V0ENQOTemKyfjYzpAKq-eF5K12tGeqE3qXHZp9x_QVEZ_E4 |
CitedBy_id | crossref_primary_10_3390_jcm11164642 crossref_primary_10_1007_s00701_021_04935_8 crossref_primary_10_1186_s12883_022_02862_4 crossref_primary_10_1136_jnis_2023_020544 crossref_primary_10_1177_15910199211060987 crossref_primary_10_20935_AcadBiol6157 crossref_primary_10_5334_jbsr_3714 crossref_primary_10_1007_s00062_024_01390_7 crossref_primary_10_1088_1361_6498_ac32a2 crossref_primary_10_3390_bioengineering10070797 |
Cites_doi | 10.3171/jns.1991.74.6.0985 10.1161/01.str.30.7.1402 10.1159/000477467 10.1136/neurintsurg-2014-011285 10.3171/jns.2004.101.1.0154 10.3171/jns.1990.73.1.0037 10.1016/j.wneu.2018.05.005 10.1161/STR.0b013e3182587839 10.1016/j.clineuro.2013.12.012 10.1136/jnis.2009.000919 10.1136/neurintsurg-2012-010572 10.1016/j.wneu.2011.02.030 10.3348/kjr.2015.16.1.180 10.3174/ajnr.A0747 10.1161/01.str.26.11.2061 10.3174/ajnr.A6124 10.3174/ajnr.A2246 10.1093/ons/opy202 10.1007/s00234-010-0752-z 10.1227/00006123-198209000-00001 10.1136/neurintsurg-2013-011043 10.1177/1591019917699980 10.1097/00006123-199905000-00022 |
ContentType | Journal Article |
Copyright | The Author(s) 2020 COPYRIGHT 2020 BioMed Central Ltd. 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2020 – notice: COPYRIGHT 2020 BioMed Central Ltd. – notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION 3V. 7TK 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s12883-020-01856-4 |
DatabaseName | Springer Nature OA Free Journals CrossRef ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1471-2377 |
EndPage | 8 |
ExternalDocumentID | oai_doaj_org_article_dba65e44d5b047c1962ae18af9a5043c PMC7339531 A628892373 10_1186_s12883_020_01856_4 |
GeographicLocations | United States--US California |
GeographicLocations_xml | – name: United States--US – name: California |
GrantInformation_xml | – fundername: Chang Gung Memorial Hospital, Linkou grantid: CMRPG3K0071 funderid: http://dx.doi.org/10.13039/501100005795 – fundername: ; grantid: CMRPG3K0071 |
GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABIVO ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IGS IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB AAYXX ALIPV CITATION 3V. 7TK 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c584t-4f4e7bf72579c3965b1f6276acd90674420f117084687460e05e182687a193993 |
IEDL.DBID | C6C |
ISSN | 1471-2377 |
IngestDate | Wed Aug 27 01:21:58 EDT 2025 Thu Aug 21 17:57:07 EDT 2025 Thu Sep 04 22:01:12 EDT 2025 Fri Jul 25 06:14:09 EDT 2025 Tue Jun 17 21:28:36 EDT 2025 Tue Sep 16 09:47:14 EDT 2025 Tue Jul 01 00:37:32 EDT 2025 Thu Apr 24 22:59:01 EDT 2025 Sat Sep 06 07:35:57 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Cerebral aneurysm Scepter XC balloon Aneurysm rupture Balloon angioplasty; subarachnoid hemorrhage |
Language | English |
License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c584t-4f4e7bf72579c3965b1f6276acd90674420f117084687460e05e182687a193993 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-6816-3963 |
OpenAccessLink | https://doi.org/10.1186/s12883-020-01856-4 |
PMID | 32635892 |
PQID | 2424785686 |
PQPubID | 44772 |
PageCount | 8 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_dba65e44d5b047c1962ae18af9a5043c pubmedcentral_primary_oai_pubmedcentral_nih_gov_7339531 proquest_miscellaneous_2421465653 proquest_journals_2424785686 gale_infotracmisc_A628892373 gale_infotracacademiconefile_A628892373 crossref_primary_10_1186_s12883_020_01856_4 crossref_citationtrail_10_1186_s12883_020_01856_4 springer_journals_10_1186_s12883_020_01856_4 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-07-07 |
PublicationDateYYYYMMDD | 2020-07-07 |
PublicationDate_xml | – month: 07 year: 2020 text: 2020-07-07 day: 07 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London |
PublicationTitle | BMC neurology |
PublicationTitleAbbrev | BMC Neurol |
PublicationYear | 2020 |
Publisher | BioMed Central BioMed Central Ltd BMC |
Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
References | ME Linskey (1856_CR10) 1991; 74 JJ Heit (1856_CR13) 2015; 7 ED Greenberg (1856_CR21) 2010; 31 AM Spiotta (1856_CR15) 2015; 7 NF Kassell (1856_CR5) 1982; 11 JL Brisman (1856_CR11) 2004; 101 NF Kassell (1856_CR3) 1990; 73 BA Gross (1856_CR17) 2017; 6 S John (1856_CR14) 2014; 6 G Seidel (1856_CR19) 1995; 26 D Cooke (1856_CR1) 2010; 2 C Charpentier (1856_CR22) 1999; 30 ES Connolly Jr (1856_CR2) 2012; 43 CM Lin (1856_CR16) 2019; 16 MA Labeyrie (1856_CR23) 2019; 40 RH Rosenwasser (1856_CR6) 1999; 44 N Badjatia (1856_CR4) 2004; 25 NS Chaudhry (1856_CR24) 2017; 23 PC Sanelli (1856_CR20) 2011; 53 N Chalouhi (1856_CR8) 2014; 118 CC Chen (1856_CR9) 2018; 116 GJ Velat (1856_CR7) 2011; 76 Y Murayama (1856_CR25) 2003; 24 YD Cho (1856_CR12) 2015; 16 AM Laslo (1856_CR18) 2008; 29 |
References_xml | – volume: 74 start-page: 985 issue: 6 year: 1991 ident: 1856_CR10 publication-title: Case report J Neurosurg doi: 10.3171/jns.1991.74.6.0985 – volume: 30 start-page: 1402 issue: 7 year: 1999 ident: 1856_CR22 publication-title: Stroke. doi: 10.1161/01.str.30.7.1402 – volume: 25 start-page: 819 issue: 5 year: 2004 ident: 1856_CR4 publication-title: AJNR Am J Neuroradiol – volume: 6 start-page: 229 issue: 3–4 year: 2017 ident: 1856_CR17 publication-title: Interv Neurol doi: 10.1159/000477467 – volume: 7 start-page: 721 issue: 10 year: 2015 ident: 1856_CR15 publication-title: J Neurointerv Surg. doi: 10.1136/neurintsurg-2014-011285 – volume: 101 start-page: 154 issue: 1 year: 2004 ident: 1856_CR11 publication-title: J Neurosurg doi: 10.3171/jns.2004.101.1.0154 – volume: 73 start-page: 37 issue: 1 year: 1990 ident: 1856_CR3 publication-title: J Neurosurg doi: 10.3171/jns.1990.73.1.0037 – volume: 116 start-page: e452 year: 2018 ident: 1856_CR9 publication-title: World Neurosurg doi: 10.1016/j.wneu.2018.05.005 – volume: 43 start-page: 1711 issue: 6 year: 2012 ident: 1856_CR2 publication-title: Stroke. doi: 10.1161/STR.0b013e3182587839 – volume: 118 start-page: 26 year: 2014 ident: 1856_CR8 publication-title: Clin Neurol Neurosurg doi: 10.1016/j.clineuro.2013.12.012 – volume: 2 start-page: 139 issue: 2 year: 2010 ident: 1856_CR1 publication-title: J Neurointerv Surg doi: 10.1136/jnis.2009.000919 – volume: 6 start-page: 125 issue: 2 year: 2014 ident: 1856_CR14 publication-title: J Neurointerv Surg. doi: 10.1136/neurintsurg-2012-010572 – volume: 76 start-page: 446 issue: 5 year: 2011 ident: 1856_CR7 publication-title: World Neurosurg doi: 10.1016/j.wneu.2011.02.030 – volume: 16 start-page: 180 issue: 1 year: 2015 ident: 1856_CR12 publication-title: Korean J Radiol doi: 10.3348/kjr.2015.16.1.180 – volume: 29 start-page: 79 issue: 1 year: 2008 ident: 1856_CR18 publication-title: AJNR Am J Neuroradiol doi: 10.3174/ajnr.A0747 – volume: 26 start-page: 2061 issue: 11 year: 1995 ident: 1856_CR19 publication-title: Stroke. doi: 10.1161/01.str.26.11.2061 – volume: 40 start-page: 1342 issue: 8 year: 2019 ident: 1856_CR23 publication-title: AJNR Am J Neuroradiol doi: 10.3174/ajnr.A6124 – volume: 24 start-page: 133 issue: 1 year: 2003 ident: 1856_CR25 publication-title: AJNR Am J Neuroradiol – volume: 31 start-page: 1853 issue: 10 year: 2010 ident: 1856_CR21 publication-title: AJNR Am J Neuroradiol doi: 10.3174/ajnr.A2246 – volume: 16 start-page: 692 issue: 6 year: 2019 ident: 1856_CR16 publication-title: Oper Neurosurg (Hagerstown) doi: 10.1093/ons/opy202 – volume: 53 start-page: 425 issue: 6 year: 2011 ident: 1856_CR20 publication-title: Neuroradiology. doi: 10.1007/s00234-010-0752-z – volume: 11 start-page: 337 issue: 3 year: 1982 ident: 1856_CR5 publication-title: Neurosurgery. doi: 10.1227/00006123-198209000-00001 – volume: 7 start-page: 56 issue: 1 year: 2015 ident: 1856_CR13 publication-title: J Neurointerv Surg doi: 10.1136/neurintsurg-2013-011043 – volume: 23 start-page: 372 issue: 4 year: 2017 ident: 1856_CR24 publication-title: Interv Neuroradiol doi: 10.1177/1591019917699980 – volume: 44 start-page: 975 issue: 5 year: 1999 ident: 1856_CR6 publication-title: Neurosurgery. doi: 10.1097/00006123-199905000-00022 |
SSID | ssj0017841 |
Score | 2.3158884 |
Snippet | Background
Cerebral vasospasm still results in high morbidity and mortality rates in patients after aneurysmal subarachnoid hemorrhage (SAH). The aim of this... Background Cerebral vasospasm still results in high morbidity and mortality rates in patients after aneurysmal subarachnoid hemorrhage (SAH). The aim of this... Cerebral vasospasm still results in high morbidity and mortality rates in patients after aneurysmal subarachnoid hemorrhage (SAH). The aim of this study was to... Abstract Background Cerebral vasospasm still results in high morbidity and mortality rates in patients after aneurysmal subarachnoid hemorrhage (SAH). The aim... |
SourceID | doaj pubmedcentral proquest gale crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database Publisher |
StartPage | 1 |
SubjectTerms | Aneurysm Aneurysm rupture Aneurysms Angiography Angioplasty Balloon angioplasty Balloon angioplasty; subarachnoid hemorrhage Balloon catheters Balloon treatment Blood pressure Cardiac patients Cardiovascular system Care and treatment CAT scans Catheters Cerebral aneurysm Cerebrovascular disease and stroke Computed tomography Consciousness Embolization Health aspects Medical imaging Medical treatment Medicine Medicine & Public Health Morbidity Mortality Neurochemistry Neurology Neurosurgery Nimodipine Patients Perfusion Research Article Scepter XC balloon Stents Stroke Subarachnoid hemorrhage Therapeutics Thromboembolism Vasoconstriction Veins & arteries |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gLojxEoCAjIXGAqHHi2MmxVK0qpPZEpb1ZfsJKNFmtd6l64q8z4yRLQwVcuGVjxzvxjO1vMvY3hLytSlMGW_Hctk6Ag9KYvPWW5Y1j1lkmDC_xvPP5hTi75J8W9eJWqi_cEzbQAw8dd-iMFrXn3NWm4NKCwZTas0aHViP5lsXZt2iLyZka4wcYTZuOyDTiMDJMqpujq1TAAgVCzZahxNZ_d06-u0_yt2BpWoNOH5GHI3ikR4PQ--Se7x6T--djePwJ-ZHoimkcGGdvaB9oxG0rfk0Xx9RgjL3vqO6-LPsVoObNDVw7Gpe4q1B3vt9GegG6c5jP2lOwvS1-S6OAa-l3HXuYfOIV_IJmrkE-ut6uMP7goBUPqolXT8nl6cnn47N8zLCQWwAem5wH7qUJEsZta6tW1IYFUUqhrWthGeO8LAKmpgGQ0kguCl_UHh2SRmoAfgBtnpG9ru_8c0JrzQJnFjTMAZRwZrw2RWVqgA_gE4UyI2zqcGVH-nHMgvFNJTekEWpQkgIlqaQkxTPyfvfMaiDf-Gvtj6jHXU0kzk43wJzUaE7qX-aUkXdoBQqHN4hn9XhKAV4SibLUEaZnBlAsq4wczGrCsLTz4smO1DgtRIVncSQI24iMvNkV45O41S3pGeswJLGroQk5s7_Zm81LuuXXRA0uq6qFWTUjHyZL_fXnf-65F_-j516SB2UaYPjp-4DsbdZb_woA28a8TmPzJ4x8PQ0 priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgL4ikCLTISEgeIGieOnZxQW1FVSO2JSnuz_EpZiSbLehfUU_96Z7zOVqGit92147UzD894xt8Q8rEqTdnZiue2dQIclMbkrbcsbxyzzjJheIn3nU_PxMk5_z6rZ-nALaS0ylEnRkXtBotn5Pt4jUE2tWjE18XvHKtGYXQ1ldB4SB5F6DLgZznbOlwMY2rjRZlG7AeGpXVzdJgK2KZgapPNKGL239XMd7Ml_wmZxp3o-Bl5mkxIerCh-XPywPcvyOPTFCR_Sa4jaDENG9zZKzp0NGDyil_S2RE1GGkfeqr7i_mwANt5dQWfHQ1zzC3UvR_WgZ4BBR1WtfYUOHCNJ2oUrFv6R4cBVFC4hG8wzF-YH12uFxiFcDCKBwKFy1fk_Pjbj6OTPNVZyC2YH6ucd9xL00mQ3tZWragN60Qphbauhc2M87LosEANmCqN5KLwRe3RLWmkBvMPDJzXZKcfev-G0FqzjjMLdOZgmnBmvDZFZWowIsAz6sqMsPGFK5tAyLEWxi8VnZFGqA2RFBBJRSIpnpHP22cWGwiOe3sfIh23PRE-O_4wLC9UkkbljBa159zVpuDSghYqNSxJd61GRDebkU_IBQqFHKZndbqrAItEuCx1gEWawTSWVUZ2Jz1BOO20eeQjlZRDULesnJEP22Z8EhPeIp2xD0MouxqGkBP-m6xs2tLPf0aAcFlVLejWjHwZOfX2z___5t7eP9d35EkZRQePtnfJzmq59ntgkK3M-yh1N-rpNDs priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwED-NISFeEJ8iMJCRkHiAQJw4dvKA0JiYJqTuiUp9s2zHGZW2pDQt0Cf-de7cpFPYQOKtqT9i--58v8vZdwAvs9SmtctE7MpKooFS2Lj0jsdFxV3luLQipfvOk1N5MhWfZ_lsD4Z0R_0CdteadpRParo8f_vz2-YDCvz7IPCFfNdxSpkbkyGUoPrBV96Am6iZJBljE3HpVSAf23Bx5tp2I-UUYvhf3amvnp78w4UaNNPxXbjTQ0p2uOWBe7Dnm_twa9I7zR_ArxDEmHXbOLQb1taso8MsfslmR8yS571tmGnO5u0CsfRqg78r1s3prKFpfLvu2ClStKIs157hGq3pCxtDtMu-m67FLam7wCfs5geOjy3XC_JKVNiLR4J1Fw9hevzpy9FJ3OddiB3CkVUsauGVrRVKc-myUuaW1zJV0riqROUmRJrUlLAGoUuhhEx8knsyUwplEA4i4HkE-03b-MfAcsNrwR3SXSBUEdx6Y5PM5ggq0FKq0wj4sODa9UHJKTfGuQ7GSSH1lkgaiaQDkbSI4PWuzWIbkuOftT8SHXc1KZx2-KNdnuleOnVljcy9EFVuE6Ec7kqpwSmZujQU4c1F8Iq4QBMb4vCc6e8u4CQpfJY-pKTNCJVVFsHBqCYKqxsXD3ykB17XdENH4WALGcGLXTG1pANwgc5Uh1Nouxy7UCP-G81sXNLMv4aA4SrLStxrI3gzcOrly_--ck_-r_pTuJ0GUaJP3wewv1qu_TMEbCv7PEjhb3abO5Y priority: 102 providerName: Scholars Portal |
Title | Early strategy of scepter XC balloon angioplasty and simultaneous Nimodipine infusion for vasospasm following ruptured aneurysm |
URI | https://link.springer.com/article/10.1186/s12883-020-01856-4 https://www.proquest.com/docview/2424785686 https://www.proquest.com/docview/2421465653 https://pubmed.ncbi.nlm.nih.gov/PMC7339531 https://doaj.org/article/dba65e44d5b047c1962ae18af9a5043c |
Volume | 20 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dixMxEB-8OxBfxE9cPUsEwQdd3Oxmk93Ha7njEFrk8KD4EpJsVgvebum2yj35rzuTbqvrqeDL0jYfTXY-8ptMMgPwMkttWrtMxK6sJBoohY1L73hcVNxVjksrUrrvPJ3J80vxbp7P-zA5dBfmV_89L-TbjlM63JiMnASXFuzuAI5ynkkSwomc7D0G5D_bXYr5Y7vBwhPi89_UwjdPRv7mHg2rztk9uNvDRXaype99uOWbB3B72jvEH8L3EKCYddsYs9esrVlHB1X8is0nzJJXvW2YaT4t2iXi5PU1fq5Yt6BzhKbxaPazGVKrogzWniG3bWj3jCGSZV9N16K66a7wG3bzDcfHVpsleRwq7MUjMbqrR3B5dvphch73ORVih1BjHYtaeGVrhZJauqyUueW1TJU0ripx4RIiTWpKRoOwpFBCJj7JPZkghTII9RDMPIbDpm38E2C54bXgDmkqEIYIbr2xSWZzBAxoBdVpBHz3wrXrA45T3osvOhgehdRbImkkkg5E0iKC1_s2y224jX_WHhMd9zUpVHb4ATlI95KnK2tk7oWocpsI5VDjpAanZOrSUPQ2F8Er4gJNAo3Dc6a_l4CTpNBY-oQSMiMMVlkEx4OaKIhuWLzjI90rgk7T7RuFgy1kBC_2xdSSDrcFOlMdTmHrcuxCDfhvMLNhSbP4HIKBqywrUY9G8GbHqT___O9v7un_VX8Gd9IgSrStfQyH69XGP0cwtrYjOFBzNYKj8ens_cUoyOQobGzgcyoKfF6MP_4AB7kyZA |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Nb9MwFLemIQEXNL5EYICRQBwgWpw4dnJAaAymjq09bVJvxnacrRJLuqZl6on_iL-R99ykU5jYbbe2dlLb7_e-_Oz3CHmbxCYubcJDmxcCHJTMhLmzLMwKZgvLhOEx3ncejsTghH8fp-MN8qe7C4PHKjuZ6AV1UVvcI9_BawwyS0UmPk8vQqwahdHVroTGChaHbnkJLlvz6eAr0PddHO9_O94bhG1VgdCCsp2HvOROmlICVnOb5CI1rBSxFNoWOYhuzuOoxHIsoJgzyUXkotShEZ5JDcZOjsmXQOTf4QnYVsA_crx28BjG8LqLOZnYaRiW8g3RQYtALcJS9JSfrxFwXRNcP535T4jWa779LfKgNVnp7gpjD8mGqx6Ru8M2KP-Y_PZJkmmzynO7pHVJGzws42Z0vEcNRvbriurqdFJPwVafL-FzQZsJnmXUlasXDR0BYgqsou0oIH6BO3gUrGn6Szc1iLzmHL7Bay5hfHS2mGLUo4C3OABEc_6EnNwKBZ6Szaqu3DNCU81KzizgioMpxJlx2kSJScFoAU-sjAPCugVXtk16jrU3firv_GRCrYikgEjKE0nxgHxYPzNdpfy4sfcXpOO6J6br9j_Us1PVcr8qjBap47xITcSlBakXa5iSLnONGeRsQN4jChQKFRie1e3dCJgkpudSu1gUGkxxmQRku9cThIHtN3c4Uq0watQV6wTkzboZn8QDdp7O2Idh6rwUXiF7-OvNrN9STc58QnKZJDnI8oB87JB69ef_X7nnN4_1Nbk3OB4eqaOD0eELcj_2bITb6ttkcz5buJdgDM7NK8-BlPy4bZb_C_XTbXs |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagSBUXxFMEChgJiQNEjRPHTo5lYVUeXXGg0t4sv1JWoslqkwX1xF9nxkkWQgGJWxI_Ymdm7JmM5xtCnmWpSSub8diWToCBUpi49JbFhWPWWSYMTzHe-WQhjk_5u2W-_CWKP5x2H12SfUwDojTV3eHaVb2IF-KwZZgkN0bTJ4ENB15ylVwDSyVBvp6J2c6PgF61MVTmj-0m21FA7b-8Nl8-L_mb0zTsRfOb5MagRNKjnuq3yBVf3yb7J4Ob_A75HmCLadsjz17QpqItHl_xG7qcUYO-9qamuj5bNWvQnrsLuHa0XeHpQl37ZtvSBdDQYV5rT4EHt_hPjYJ-S7_qtoFFqD2HO-jmG4yPbrZr9EM46MUDidrzu-R0_ubT7DgeMi3EFhSQLuYV99JUEuS3tFkpcsMqkUqhrSthO-M8TSpMUQPKSiG5SHySezRMCqlBAQQV5x7Zq5va3yc016zizAKlOSgnnBmvTZKZHNQIsI2qNCJs_ODKDjDkmA3jiwrmSCFUTyQFRFKBSIpH5MWuzboH4fhn7VdIx11NBNAOD5rNmRrkUTmjRe45d7lJuLSwDqUapqSrUiOmm43Ic-QChWIOw7N6iFaASSJgljrCNM2gHMssIgeTmiCedlo88pEalodWYUyOhMEWIiJPd8XYEo-8BTpjHYZgdjl0ISf8N5nZtKRefQ4Q4TLLSlhdI_Jy5NSfL__7l3vwf9WfkP2Pr-fqw9vF-4fkehqkCv97H5C9brP1j0Bb68zjIJA_AHftOEM |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Early+strategy+of+scepter+XC+balloon+angioplasty+and+simultaneous+Nimodipine+infusion+for+vasospasm+following+ruptured+aneurysm&rft.jtitle=BMC+neurology&rft.au=Chen%2C+Chun-Ting&rft.au=Chen%2C+Ching-Chang&rft.au=Wang%2C+Alvin+Yi-Chou&rft.au=Wu%2C+Yi-Ming&rft.date=2020-07-07&rft.pub=BioMed+Central&rft.eissn=1471-2377&rft.volume=20&rft.issue=1&rft_id=info:doi/10.1186%2Fs12883-020-01856-4&rft.externalDocID=10_1186_s12883_020_01856_4 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2377&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2377&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2377&client=summon |